Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -81.4% | -33.0% | 0 / 3 | -14.4% | -1.91 pp | -2.51 pp | -20.6% | 0.70 | — | 67,0 | −14,4% | −2,9 | −101,7% | — | -2.67 | — |
| Pts | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 4.600 (close price on 2026-10-15)EPS (TTM): −2.231,4
Financial charts
1.Revenue & growth
VND bn67,0Q3/26
1.Revenue & growth
VND bn67,0Q3/26
2.Profit & growth
VND bn-2,92Q3/26
3.Profit mix (Penman)
VND bn-11,3Q3/26
4.Margins & cost structure
%3.9%Q3/26
5.Returns & cash cycle
% · days-3.7%Q3/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn90,3Q3/26
8.Funding & debt health
VND bn · times90,3Q3/26
9.Revenue backlog
VND bn0,54Q3/26
10.Valuation
times · %-2,0×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-531Q3/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26